Dopamine release in human ventral striatum and expectation of reward

Behav Brain Res. 2002 Nov 15;136(2):359-63. doi: 10.1016/s0166-4328(02)00130-4.

Abstract

Using the ability of [11C]raclopride to compete with dopamine for D(2)/D(3) receptors, we investigated by positron emission tomography the effect of placebo (saline) injection on dopamine release in the ventral striatum of patients with Parkinson's disease. We found evidence for placebo-induced dopamine release of similar magnitude to that reported in healthy volunteers after amphetamine administration. However, in contrast to the dorsal striatum, there were no differences in [11C]raclopride binding potential changes between patients who experienced the reward (those who reported placebo-induced clinical benefit) and those who did not. We conclude that the release of dopamine in the ventral striatum (nucleus accumbens) is related to the expectation of reward and not to the reward itself. These observations have potential implications for the treatment of drug addiction.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparkinson Agents / pharmacology
  • Apomorphine / pharmacology
  • Dopamine / metabolism*
  • Dopamine Antagonists
  • Humans
  • Neostriatum / diagnostic imaging
  • Neostriatum / metabolism*
  • Nucleus Accumbens / diagnostic imaging
  • Nucleus Accumbens / metabolism
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / metabolism
  • Parkinson Disease / psychology
  • Raclopride
  • Reward*
  • Tomography, Emission-Computed

Substances

  • Antiparkinson Agents
  • Dopamine Antagonists
  • Raclopride
  • Apomorphine
  • Dopamine